---
$id: https://graph.org.ai/products/commodity/51321809
$type: Product
source: UNSPSC
code: "51321809"
title: "Gemfibrozil"
class: "51321800"
classTitle: "Antihyperlipidemic and hypocholesterolemic fibric acids"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gemfibrozil

**UNSPSC Code**: 51321809
**Class**: [Antihyperlipidemic and hypocholesterolemic fibric acids](Antihyperlipidemic and hypocholesterolemic fibric acids.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent with the molecular formula C15H22O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q8X02027X3, chemically known as 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid but generally known as gemfibrozil, which bears US NIH Compound Identifier 3463. European Medicines Agency schedules Gemfibrozil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07894MIG. The term GEMFIBROZIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules gemfibrozil in its Anatomical Therapeutic Chemical (ATC) Classification. GEMFIBROZIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, GEMFIBROZIL remains the US FDA Preferred Term for this commodity. Gemfibrozil bears US NLM identifiers UMLS ID C0017245 and NCI Concept Code C29071. SMILES: O(CCCC(C)(C)C(=O)O)c1c(ccc(c1)C)C.

